Over the past one year, enterprises had to overcome a series of macroeconomic and geopolitical challenges. The potential uncertainties with the implementation of the Inflation Regulation Act (IRA), and the rise in federal interest rates to curb inflation, compounded by an ongoing war resulting in shifting of clinical trials from Russia and Ukraine, have forced enterprises to rethink their strategies. Further, the advent of generative AI such as ChatGPT will enable the biopharma and MedTech firms to repackage their offerings and provide cutting-edge technology and cost optimization.

To effectively serve the evolving enterprise needs, service providers have invested in increasing the breadth and depth of their functionalities/offerings across the life sciences operations value chain. They have invested in a host of avenues such as Decentralized Clinical Trials (DCT), with many Information Technology / Business Process Outsourcing (IT/BPOs) companies partnering with DCT providers. Further investments include analytics-driven tools for razor-sharp Healthcare Professional (HCP) profiling and targeting, and the use of automation tools in areas such as Adverse Events (AE) intakes to rapidly evolve with the market needs.

In this research, we present a detailed assessment of 28 operations service providers featured on the Life Sciences Operations Services PEAK Matrix^®. We provide a relative positioning and analysis of the providers’ market shares, along with our evaluation of their strengths and limitations. This report will enable enterprises to identify suitable service providers to manage the evolving needs of their businesses.

Scope

• Industry: life sciences BPS
• Geography: global
• The assessment is based on Everest Group’s annual RFI process for calendar year 2023, interactions with leading life sciences operations service providers, client reference checks, and an ongoing analysis of the life sciences operations market.

Contents

This report provides a detailed analysis of 28 operations service providers and includes:

• Relative positioning of the providers on Everest Group’s PEAK Matrix^® for Life Sciences Operations Services
• Comparison of the providers’ capabilities and market shares
• Everest Group’s analysis of the providers’ strengths and limitations

Membership(s)

Life Sciences Business Process

Sourcing and Vendor Management